|
|
Effect of Salvia Miltiorrhiza Injection in the treatment of type Ⅱ respiratory failure and its influence on respiratory function and hemodynamics |
LIU Jing1 LI Lei2 FENG Fei2 WANG Meng2 HAO Likun2 GAO Chao2 YANG Huimin2 |
1.Department of Traditional Chinese Medicine, the First Central Hospital of Baoding City, Hebei Province, Baoding 071000, China;
2.Department of Critical Care Medicine, the First Traditional Chinese Medicine Hospital of Baoding City, Hebei Province, Baoding 071000, China |
|
|
Abstract Objective To explore the effect of Salvia Miltiorrhiza Injection in the treatment of type Ⅱ respiratory failure and its influence on respiratory function and hemodynamics. Methods From June 2015 to February 2018, 80 patients with type Ⅱ respiratory failure admitted to the First Central Hospital of Baoding City in Hebei Province were selected as subjects. All patients were divided into control group (conventional treatment, 40 cases) and observation group (conventional treatment combined with Salvia Miltiorrhiza Injection, 40 cases) by random number table method. The treatment effects, respiratory function indexes [forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), FEV1/FVC, PaO2, PaCO2] and hemodynamic parameters [heart rate (HR), mean arterial pressure (MAP), central venous pressure (CVP), stroke volume (SV), cardiac output (CO), thoracic fluid content (TFC), systemic vascular resistance (SVR), pulmonary vessel resistance (PVR)] were observed. Results There was significant difference in the total effective rate between the two groups (P < 0.05). After treatment, the indexes of FVC, FEV1, FEV1/FVC, PaO2 and PaCO2 in two groups were improved compared with those before treatment, and the improvement in observation group was more obvious than that in control group, the differences were statistically significant (P < 0.05). After treatment, the indexes of HR, MAP, CVP, SV, TFC and PVR in two groups were improved compared with those before treatment, and the improvement in observation group was more obvious than that in control group, the differences were statistically significant (P < 0.05). Conclusion Salvia Miltiorrhiza Injection can effectively improve the respiratory function and hemodynamics of patients with type Ⅱ respiratory failure and improve the clinical treatment effect.
|
|
|
|
|
[1] Hayward RA,Reaven PD,Wiitala WL,et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes [J]. New Engl J Med,2015,372(23):2197-2206.
[2] Fahy JV. Type 2 inflammation in asthma—present in most,absent in many [J]. Nat Rev Immunol,2015,15(1):57-64.
[3] 苏从肖,赵丽肖,吴春秀,等.无创机械通气辅助自拟活血化瘀方联合纳洛酮治疗慢性阻塞性肺疾病并呼吸衰竭的临床价值探究[J].医疗装备,2015,28(12):146-147.
[4] 陆敬宪,鲍林林.益气活血化瘀法联合无创辅助通气治疗慢阻肺急性加重期呼吸衰竭的临床分析[J].中医临床研究,2017,9(29):32-34.
[5] 林桂平,卢春颜,邝巧芬,等.复方丹参注射液抗心肌缺血及活血化瘀作用的实验研究[J].中国中医药科技,2014, 21(3):251-253.
[6] 庞汉青,唐于平,史旭芹,等.基于主成分分析和多指标综合指数法丹参不同有效部位的活血化瘀作用比较[J].中草药,2016,47(18):3239-3247.
[7] 林志国.无创正压通气治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者的疗效[J].中国老年学杂志,2012,32(3):621-622.
[8] 中华医学会重症医学分会.慢性阻塞性肺疾病急性加重患者机械通气指南(2007)[J].中华急诊医学杂志,2007, 16(4):350-357.
[9] 安福成.综合治疗对老年慢性阻塞性肺疾病所致急性呼吸衰竭患者的临床疗效研究[J].中国全科医学,2017,20(9):1049-1054.
[10] 陈岩.丹参注射液与依达拉奉联合治疗急性脑梗死的临床疗效分析[J].中国现代药物应用,2016,10(2):174-175.
[11] 冯莉嵋,周元芳,李莉,等.丹参多酚酸盐注射液与丹参注射液在冠心病治疗中疗效和安全性对比[J].辽宁中医药大学学报,2016,18(11):183-185.
[12] 江平飞,胡强.血流动力学及呼吸力学参数在呼吸衰竭患者中的变化[J].昆明医科大学学报,2018,39(8):51-54.
[13] 朱建明,刘吉国,贡联兵,等.慢性阻塞性肺疾病中成药的合理应用[J].人民军医,2018,61(6):559-561.
[14] 王明航,李建生,余学庆,等.慢性阻塞性肺疾病呼吸衰竭中医证候要素分布规律的临床文献分析[J].上海中医药大学学报,2009,23(4):35-37.
[15] 李雷,李琛琦,杨慧敏,等.丹参注射液对于AECOPD合并Ⅱ型呼吸衰竭患者肺功能、动脉血气的影响[J].临床医药文献电子杂志,2017,4(76):14996-14997,14999.
[16] 贠春梅,刘华,敬金焕.丹参注射液联合布地奈德/福莫特罗对老年AECOPD患者血气指标,血液流变学,内皮细胞功能的影响[J].中华全科医学,2015,13(7):1057-1059.
[17] 杨慧敏,李雷,李琛琦.丹参注射液对COPD合并Ⅱ型呼吸衰竭患者血液流变学及高凝状态影响[J].临床医药文献杂志:电子版,2016,3(44):8839-8840.
[18] 冯永海,李宏云,秦超.黄芪注射液联合丹参注射液治疗慢性阻塞性肺疾病临床研究及对患者氧化应激水平的影响[J].陕西中医,2018,39(8):1048-1050.
[19] 付萍.中药丹参治疗冠心病的药理成分及作用研究[J].中西医结合心血管病杂志:电子版,2015,3(28):183-184.
[20] 廖正寿,冯砚瑜,唐诚,等.阿托伐他汀与丹参多酚联合治疗慢性阻塞性肺疾病合并肺动脉高压患者的临床效果观察[J].中国医药科学,2017,7(17):91-93,134.
[21] 李学林,姚保杰,李春晓.丹参及其制剂对血小板功能影响的研究进展[J].中国药房,2013,24(7):670-672. |
|
|
|